Clinical Trials
561
Active:14
Completed:278
Trial Phases
5 Phases
Phase 1:20
Phase 2:40
Phase 3:28
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (465 trials with phase data)• Click on a phase to view related trials
Not Applicable
326 (70.1%)Phase 4
51 (11.0%)Phase 2
40 (8.6%)Phase 3
28 (6.0%)Phase 1
20 (4.3%)Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases
Not Applicable
Not yet recruiting
- Conditions
- Rheumatoid Arthritis (RA)Juvenile Idiopathic Arthritis (JIA)Systemic Lupus Erythematosus (SLE)Juvenile Systemic Lupus ErythematosusSjögren's DiseaseSystemic Sclerosis (SSc)Idiopathic Inflammatory Myopathies (IIMs)Axial SpondyloarthritisPsoriatic Arthritis (PsA)Granulomatosis With Polyangiitis
- Interventions
- First Posted Date
- 2025-07-28
- Last Posted Date
- 2025-07-28
- Lead Sponsor
- University of Sao Paulo General Hospital
- Target Recruit Count
- 477
- Registration Number
- NCT07087912
- Locations
- 🇧🇷
Hospital das Clínicas da Faculdade de Medicina da USP, São Paulo, SP, Brazil
🇧🇷Rheumatology Division, Faculdade de Medicina da USP, São Paulo, SP, Brazil
Clinical Trial Phase I/IIa to Evaluate the Safety and Immunogenicity of StreptInCor
Not Applicable
Not yet recruiting
- Conditions
- Rheumatic Heart DiseaseRheumatic Heart Disease in ChildrenVaccine Adverse ReactionRheumatic DiseasesVaccine AcceptanceVaccine
- Interventions
- Other: PlaceboBiological: StrepIncor
- First Posted Date
- 2025-07-22
- Last Posted Date
- 2025-07-22
- Lead Sponsor
- University of Sao Paulo General Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT07078357
- Locations
- 🇧🇷
Heart Institute - Hospital Das Clinicas Da Faculdade de Medicina Da Universidade de São Paulo, São Paulo, SP, Brazil
The Impact of ERA Switching on Risk Stratification in Pulmonary Arterial Hypertension
Not yet recruiting
- Conditions
- Pulmonary Arterial HypertensionPulmonary Arterial Hypertension (PAH)Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)
- First Posted Date
- 2025-06-10
- Last Posted Date
- 2025-07-08
- Lead Sponsor
- University of Sao Paulo General Hospital
- Target Recruit Count
- 121
- Registration Number
- NCT07013149
- Locations
- 🇧🇷
InCor - FMUSP, São Paulo, SP, Brazil
Sedentary Behavior and Depressive Symptoms
Not Applicable
Recruiting
- Conditions
- Depression, Anxiety
- First Posted Date
- 2025-06-05
- Last Posted Date
- 2025-07-25
- Lead Sponsor
- University of Sao Paulo General Hospital
- Target Recruit Count
- 84
- Registration Number
- NCT07007234
- Locations
- 🇧🇷
University of Santo Amaro, São Paulo, SO, Brazil
🇧🇷University Santo Amaro, Sao Paulo, SP, Brazil
PulmonAry hyperteNsion DiagnOsis: a National cohoRt reseArch
Not yet recruiting
- Conditions
- Pulmonary Arterial Hypertension (PAH)Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)Pulmonary Arterial Hypertension
- First Posted Date
- 2025-05-31
- Last Posted Date
- 2025-05-31
- Lead Sponsor
- University of Sao Paulo General Hospital
- Target Recruit Count
- 139
- Registration Number
- NCT06998329
- Locations
- 🇧🇷
InCor - Universidade de São Paulo, São Paulo, SP, Brazil
- Prev
- 1
- 2
- 3
- 4
- 5
- 113
- Next
News
No news found